CUTIVATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cutivate, and when can generic versions of Cutivate launch?
Cutivate is a drug marketed by Fougera Pharms and is included in three NDAs.
The generic ingredient in CUTIVATE is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Seventy-eight suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cutivate
A generic version of CUTIVATE was approved as fluticasone propionate by FOUGERA PHARMS on May 14th, 2004.
Summary for CUTIVATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 3 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CUTIVATE |
What excipients (inactive ingredients) are in CUTIVATE? | CUTIVATE excipients list |
DailyMed Link: | CUTIVATE at DailyMed |
Recent Clinical Trials for CUTIVATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fougera Pharmaceuticals Inc. | Phase 4 |
Novartis Pharmaceuticals | Phase 4 |
Children's Hospital of Philadelphia | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for CUTIVATE
Paragraph IV (Patent) Challenges for CUTIVATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
CUTIVATE | Lotion | fluticasone propionate | 0.05% | 021152 | 1 | 2008-07-28 |
US Patents and Regulatory Information for CUTIVATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera Pharms | CUTIVATE | fluticasone propionate | CREAM;TOPICAL | 019958-001 | Dec 18, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fougera Pharms | CUTIVATE | fluticasone propionate | LOTION;TOPICAL | 021152-001 | Mar 31, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fougera Pharms | CUTIVATE | fluticasone propionate | OINTMENT;TOPICAL | 019957-001 | Dec 14, 1990 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CUTIVATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Fougera Pharms | CUTIVATE | fluticasone propionate | OINTMENT;TOPICAL | 019957-001 | Dec 14, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Fougera Pharms | CUTIVATE | fluticasone propionate | CREAM;TOPICAL | 019958-001 | Dec 18, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Fougera Pharms | CUTIVATE | fluticasone propionate | LOTION;TOPICAL | 021152-001 | Mar 31, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CUTIVATE
See the table below for patents covering CUTIVATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 8402317 | ⤷ Try a Trial | |
Australia | 6729881 | ⤷ Try a Trial | |
Austria | 395429 | ⤷ Try a Trial | |
New Zealand | 510949 | Fluticasone lotion having improved vasoconstrictor activity | ⤷ Try a Trial |
Norway | 20011911 | ⤷ Try a Trial | |
Philippines | 24267 | ANDROSTANE CARBOTHIOATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for CUTIVATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2506844 | 18C1022 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (EN PARTICULIER LE BROMURE D'UMECLIDINIUM), DU VILANTEROL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (EN PARTICULIER LE TRIFENATATE DE VILANTEROL), ET DU FUROATE DE FLUTICASONE; REGISTRATION NO/DATE: EU/1/17/1236 20171117 |
1519731 | 92269 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
1305329 | 08C0014 | France | ⤷ Try a Trial | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
2506844 | 1890025-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: COMBINATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF (E.G. VILANTEROL TRIFENATATE) AND FLUTICASONE FUROATE.; REG. NO/DATE: EU/1/17/1236 20171117 |
1519731 | 132013902182575 | Italy | ⤷ Try a Trial | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
2506844 | 2018C/022 | Belgium | ⤷ Try a Trial | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |